BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
OPEXA THERAPEUTICS (NQ: OPXA)
1.630 USD  -0.025 (-1.51%)
Streaming Delayed Price  /  Updated: 1:03 PM EDT, Apr 23, 2014  /  Add to My Watchlist      
(OPXA) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
April 23, 2014
(Penny Stock DD, 2/9/11)
Opexa Therapeutics Inc. (NASDAQ:OPXA) moved down by 18.14% and closed at $1.94 whereas overall traded volume stood at 3.03 million shares for the day. Its...(read more)
(Penny Stock DD, 1/6/11)
Zalicus, Inc. (NASDAQ:ZLCS) surged by 11.67% and closed at $2.01 with overall traded volume of 5.03 million shares in the last trading session. Its...(read more)
(tickerspy.com, 9/13/10)
Micro-cap stem cell research firm Opexa Therapeutics (OPXA) surged higher by 70% on Monday, ahead of the firm's presentation at the Rodman & Renshaw healthcare conference tomorrow. This morning, boutique research firm Vista...(read more)
Opexa Therapeutics (OPXA) Company Overview

There is no analysis for OPXA yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here